Valuation — not yet established
No valuation for Cerecin is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($316.7M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Cerecin
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Debt | $3.7M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $7.2M | ▮ | ▮ |
| Sep 2021 | Early Stage VC | $10.0M | ▮ | ▮ |
| Jan 2021 | Early Stage VC | $10.0M | ▮ | ▮ |
How Cerecin's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cerecin, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Cerecin raised?
- Cerecin has raised $316.7M in total funding across 4 recorded rounds.
- When did Cerecin last raise?
- Cerecin last raised in Jun 2024 (Debt), raising $3.7M.